Research dossier

Semax — ACTH fragment and BDNF expression dossier

A heptapeptide derived from an ACTH fragment stripped of hormonal activity.

6 min read · Purpeptide Research Desk ·

Translated from the French original, which remains the reference version: lire en français →

Semax — research dossier illustration

Molecular identity

ParameterValue
CAS number80714-61-0
Molar mass813.92 g/mol
Molecular formulaC₃₇H₅₁N₉O₁₀S
Sequence / natureMet-Glu-His-Phe-Pro-Gly-Pro
Purity≥99%
AppearanceWhite lyophilised powder

The values above correspond to the catalogue lot and are reproduced as they stand from the product page. Any discrepancy between this dossier and the product page should be reported before use.

Research context

ACTH fragments without endocrine activity are a family explored for several decades as a way of separating central effects from hormonal ones. Semax is the best documented representative of that approach, and the Pro-Gly-Pro extension it carries has become a stabilisation strategy used on other sequences.

Mechanism studied

Semax is a heptapeptide built from the ACTH(4-7) fragment, to which a Pro-Gly-Pro extension is added at the C-terminus. This fragment of the corticotropic hormone lacks the endocrine activity of the whole molecule: the portion responsible for adrenal stimulation is not present in it.

The Pro-Gly-Pro extension plays a documented structural role: it very appreciably slows degradation by aminopeptidases, which distinguishes Semax from the bare fragment and explains its stability in biological media.

The mechanism most studied in vitro concerns the expression of BDNF (brain-derived neurotrophic factor) and of its TrkB receptor, measured by RT-qPCR and western blot on neuronal cultures and neuron-like cell lines. Work has also reported modulation of the expression of dopaminergic and serotonergic system genes by transcriptomic analysis.

In-vitro literature

The models reported are mostly primary rodent neuronal cultures and PC12-type cell lines. A notable part of the literature is published in Russian, which limits independent replication.

Bibliographic entry points

These links are an entry point into the literature, not an edited selection. None of the sources cited relates to a human use of this material, and consulting them directly is recommended for any protocol design.

Distinguishing this compound from its analogues

Derived from ACTH(4-7) but without corticotropic activity: do not transfer data relating to whole ACTH.

The CAS number shown on the product page is the identifier to rely on. Trade names, development codes and customary abbreviations vary from one source to another and are not a reliable identification.

Methodological limits

The Pro-Gly-Pro extension substantially changes stability relative to the bare ACTH fragment, which makes comparisons with the literature on the native fragment of little relevance. A notable part of the literature is Russian-language, and independent replication outside that setting remains limited.

These limits are not formalities: they determine what a protocol using this material can and cannot establish. Making them explicit in the experimental plan avoids attributing to the compound an observation that belongs to the measurement system.

Analytical parameters

A heptapeptide with no particular modification. A standard chromatographic profile, with synthesis impurities well resolved on a C18 gradient.

ParameterValue
StorageStore at −20 °C, protected from light
SolubilitySoluble in bacteriostatic water (BAC)
StabilityStable for 24 months at −20 °C; 30 days after reconstitution at 2–8 °C
Control methodsRP-HPLC · MS · NMR

Reconstitution is a matter for the experimental protocol. The volume of solvent determines the final concentration and is not prescribed here: it depends on the design of the experiment and the conditions of the assay.

Resulting concentrations

The table below is arithmetic: it gives the concentration obtained for a given solvent volume, with no recommendation of use.

Format1 ml2 ml3 ml
10mg10.00 mg/ml5.00 mg/ml3.33 mg/ml
30mg30.00 mg/ml15.00 mg/ml10.00 mg/ml

These values assume complete dissolution and a peptide content consistent with the lot report. Where the actual quantitative content differs from the nominal mass — a common discrepancy, caused by counter-ions and residual water — the effective concentration is lower than the theoretical value. That is precisely why quantitative content per vial forms part of the verification protocol.

Protocol design

Three points govern the validity of an assay using this material, whatever the question being asked.

The effective concentration is not the nominal concentration. It depends on the actual peptide content of the lot, on complete dissolution and on adsorption to the walls of the container. A concentration check after reconstitution is preferable to assuming a perfect yield.

The actual exposure time may be shorter than the nominal duration where the compound is degraded by the medium. Verify stability under the exact conditions of the assay — medium, serum, temperature, duration — before interpreting an absence of effect.

The control arm must correspond to the vehicle actually used, at the same final concentration. This requirement is unremarkable and remains the most frequent cause of irreproducible results.

Lot verification

The following formats are covered by a Janoshik Analytical report, readable from the product page:

  • 10mg — lot report available
  • 30mg — lot report available
FormatLot reportAvailability
10mgCoveredIn stock
30mgCoveredIn stock

The verification programme covers exclusively the identity and purity of the material, by reversed-phase chromatography and mass spectrometry. It covers neither sterility, nor endotoxins, nor any microbiological characteristic.

Frequently asked questions

How does this product arrive?

As a lyophilised powder in a sealed vial, shipped in insulated, plain packaging. Return the vial to the storage temperature given in the specifications on receipt.

Which solvent should be used for reconstitution?

Bacteriostatic water is the usual reconstitution solvent for lyophilised peptides in a laboratory setting. The volume is a matter for the experimental protocol and the concentration sought; we provide no dosage recommendation.

How long does the material remain stable?

The stability window appears in the specifications table on this page, before and after reconstitution. Those values correspond to the storage conditions stated; any temperature variation shortens them.

Does the analysis report correspond exactly to my vial?

The report linked on this page corresponds to the format selected. Each report is issued by Janoshik Analytical from an anonymously submitted sample, and covers the identity and purity of the peptide.

Can this product be used on humans or animals?

No. It is an analytical grade reference material intended exclusively for in-vitro laboratory research. Any administration to humans or animals is excluded, and no therapeutic, diagnostic or medical claim is made.

See also: Semax or Selank: the comparison

Dossiers in the same category

  • Adamax — CAS N/A (research blend)
  • Selank — CAS 129954-34-3

Related dossiers

All research dossiers → · Catalogue → · Glossary →